ロスオブレジスタンス（LOR）シ​​リンジのグローバル市場インサイト・予測（～2027年）

• 英文タイトル：Global Loss-Of-Resistance(LOR) Syringe Market Insights and Forecast to 2027

• レポートコード：QY2112C03469 • 出版社/出版日：QYResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療装置

• 販売価格（消費税別）

Single User	￥686,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,029,000 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,372,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査資料はロスオブレジスタンス（LOR）シ​​リンジの世界市場の現状について調査・分析し、2027年までの市場を予測しました。ロスオブレジスタンス（LOR）シ​​リンジの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（5ミリリットル、10ミリリットル、その他）、用途別市場規模（病院、クリニック、実験室、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・ロスオブレジスタンス（LOR）シ​​リンジの世界市場概要 ・メーカー別の競争状況、市場シェア ・ロスオブレジスタンス（LOR）シ​​リンジの種類別市場規模：5ミリリットル、10ミリリットル、その他 ・ロスオブレジスタンス（LOR）シ​​リンジの用途別市場規模：病院、クリニック、実験室、その他 ・北米のロスオブレジスタンス（LOR）シ​​リンジ市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパのロスオブレジスタンス（LOR）シ​​リンジ市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアのロスオブレジスタンス（LOR）シ​​リンジ市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米のロスオブレジスタンス（LOR）シ​​リンジ市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカのロスオブレジスタンス（LOR）シ​​リンジ市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：B Braun Medical、Smiths Medical、Spectra Medical Devices、Busse Hospital Disposables、Medline、Teleflex Medical、BD、Halyard Health、Avanos Medical ・ロスオブレジスタンス（LOR）シ​​リンジのバリューチェーン・販売チャネル分析 ・ロスオブレジスタンス（LOR）シ​​リンジの世界市場動向

Market Analysis and Insights: Global Loss-Of-Resistance(LOR) Syringe Market
The global Loss-Of-Resistance(LOR) Syringe market is valued at US$ million in 2020. The market size will reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027.

Global Loss-Of-Resistance(LOR) Syringe Scope and Segment
Loss-Of-Resistance(LOR) Syringe market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Loss-Of-Resistance(LOR) Syringe market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
5 Milliliters
10 Milliliters
Others

Segment by Application
Hospital
Clinic
Laboratory
Others

By Company
B Braun Medical
Smiths Medical
Spectra Medical Devices
Busse Hospital Disposables
Medline
Teleflex Medical
BD
Halyard Health
Avanos Medical

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Loss-Of-Resistance(LOR) Syringe Product Introduction
1.2 Market by Type
1.2.1 Global Loss-Of-Resistance(LOR) Syringe Market Size Growth Rate by Type
1.2.2 5 Milliliters
1.2.3 10 Milliliters
1.2.4 Others
1.3 Market by Application
1.3.1 Global Loss-Of-Resistance(LOR) Syringe Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Laboratory
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Loss-Of-Resistance(LOR) Syringe Sales Estimates and Forecasts 2016-2027
2.2 Global Loss-Of-Resistance(LOR) Syringe Revenue Estimates and Forecasts 2016-2027
2.3 Global Loss-Of-Resistance(LOR) Syringe Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Loss-Of-Resistance(LOR) Syringe Regions by Sales
2.4.1 Global Top Loss-Of-Resistance(LOR) Syringe Regions by Sales (2016-2021)
2.4.2 Global Top Loss-Of-Resistance(LOR) Syringe Regions by Sales (2022-2027)
2.5 Global Top Loss-Of-Resistance(LOR) Syringe Regions by Revenue
2.5.1 Global Top Loss-Of-Resistance(LOR) Syringe Regions by Revenue (2016-2021)
2.5.2 Global Top Loss-Of-Resistance(LOR) Syringe Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers
3.1 Global Loss-Of-Resistance(LOR) Syringe Sales by Manufacturers
3.1.1 Global Top Loss-Of-Resistance(LOR) Syringe Manufacturers by Sales (2016-2021)
3.1.2 Global Top Loss-Of-Resistance(LOR) Syringe Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Loss-Of-Resistance(LOR) Syringe Sales in 2020
3.2 Global Loss-Of-Resistance(LOR) Syringe Revenue by Manufacturers
3.2.1 Global Top Loss-Of-Resistance(LOR) Syringe Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Loss-Of-Resistance(LOR) Syringe Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Loss-Of-Resistance(LOR) Syringe Revenue in 2020
3.3 Global Loss-Of-Resistance(LOR) Syringe Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Loss-Of-Resistance(LOR) Syringe Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Loss-Of-Resistance(LOR) Syringe Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Loss-Of-Resistance(LOR) Syringe Sales by Type
4.1.1 Global Loss-Of-Resistance(LOR) Syringe Historical Sales by Type (2016-2021)
4.1.2 Global Loss-Of-Resistance(LOR) Syringe Forecasted Sales by Type (2022-2027)
4.1.3 Global Loss-Of-Resistance(LOR) Syringe Sales Market Share by Type (2016-2027)
4.2 Global Loss-Of-Resistance(LOR) Syringe Revenue by Type
4.2.1 Global Loss-Of-Resistance(LOR) Syringe Historical Revenue by Type (2016-2021)
4.2.2 Global Loss-Of-Resistance(LOR) Syringe Forecasted Revenue by Type (2022-2027)
4.2.3 Global Loss-Of-Resistance(LOR) Syringe Revenue Market Share by Type (2016-2027)
4.3 Global Loss-Of-Resistance(LOR) Syringe Price by Type
4.3.1 Global Loss-Of-Resistance(LOR) Syringe Price by Type (2016-2021)
4.3.2 Global Loss-Of-Resistance(LOR) Syringe Price Forecast by Type (2022-2027)

5 Market Size by Application
5.1 Global Loss-Of-Resistance(LOR) Syringe Sales by Application
5.1.1 Global Loss-Of-Resistance(LOR) Syringe Historical Sales by Application (2016-2021)
5.1.2 Global Loss-Of-Resistance(LOR) Syringe Forecasted Sales by Application (2022-2027)
5.1.3 Global Loss-Of-Resistance(LOR) Syringe Sales Market Share by Application (2016-2027)
5.2 Global Loss-Of-Resistance(LOR) Syringe Revenue by Application
5.2.1 Global Loss-Of-Resistance(LOR) Syringe Historical Revenue by Application (2016-2021)
5.2.2 Global Loss-Of-Resistance(LOR) Syringe Forecasted Revenue by Application (2022-2027)
5.2.3 Global Loss-Of-Resistance(LOR) Syringe Revenue Market Share by Application (2016-2027)
5.3 Global Loss-Of-Resistance(LOR) Syringe Price by Application
5.3.1 Global Loss-Of-Resistance(LOR) Syringe Price by Application (2016-2021)
5.3.2 Global Loss-Of-Resistance(LOR) Syringe Price Forecast by Application (2022-2027)

6 North America
6.1 North America Loss-Of-Resistance(LOR) Syringe Market Size by Type
6.1.1 North America Loss-Of-Resistance(LOR) Syringe Sales by Type (2016-2027)
6.1.2 North America Loss-Of-Resistance(LOR) Syringe Revenue by Type (2016-2027)
6.2 North America Loss-Of-Resistance(LOR) Syringe Market Size by Application
6.2.1 North America Loss-Of-Resistance(LOR) Syringe Sales by Application (2016-2027)
6.2.2 North America Loss-Of-Resistance(LOR) Syringe Revenue by Application (2016-2027)
6.3 North America Loss-Of-Resistance(LOR) Syringe Market Size by Country
6.3.1 North America Loss-Of-Resistance(LOR) Syringe Sales by Country (2016-2027)
6.3.2 North America Loss-Of-Resistance(LOR) Syringe Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada

7 Europe
7.1 Europe Loss-Of-Resistance(LOR) Syringe Market Size by Type
7.1.1 Europe Loss-Of-Resistance(LOR) Syringe Sales by Type (2016-2027)
7.1.2 Europe Loss-Of-Resistance(LOR) Syringe Revenue by Type (2016-2027)
7.2 Europe Loss-Of-Resistance(LOR) Syringe Market Size by Application
7.2.1 Europe Loss-Of-Resistance(LOR) Syringe Sales by Application (2016-2027)
7.2.2 Europe Loss-Of-Resistance(LOR) Syringe Revenue by Application (2016-2027)
7.3 Europe Loss-Of-Resistance(LOR) Syringe Market Size by Country
7.3.1 Europe Loss-Of-Resistance(LOR) Syringe Sales by Country (2016-2027)
7.3.2 Europe Loss-Of-Resistance(LOR) Syringe Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia

8 Asia Pacific
8.1 Asia Pacific Loss-Of-Resistance(LOR) Syringe Market Size by Type
8.1.1 Asia Pacific Loss-Of-Resistance(LOR) Syringe Sales by Type (2016-2027)
8.1.2 Asia Pacific Loss-Of-Resistance(LOR) Syringe Revenue by Type (2016-2027)
8.2 Asia Pacific Loss-Of-Resistance(LOR) Syringe Market Size by Application
8.2.1 Asia Pacific Loss-Of-Resistance(LOR) Syringe Sales by Application (2016-2027)
8.2.2 Asia Pacific Loss-Of-Resistance(LOR) Syringe Revenue by Application (2016-2027)
8.3 Asia Pacific Loss-Of-Resistance(LOR) Syringe Market Size by Region
8.3.1 Asia Pacific Loss-Of-Resistance(LOR) Syringe Sales by Region (2016-2027)
8.3.2 Asia Pacific Loss-Of-Resistance(LOR) Syringe Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia

9 Latin America
9.1 Latin America Loss-Of-Resistance(LOR) Syringe Market Size by Type
9.1.1 Latin America Loss-Of-Resistance(LOR) Syringe Sales by Type (2016-2027)
9.1.2 Latin America Loss-Of-Resistance(LOR) Syringe Revenue by Type (2016-2027)
9.2 Latin America Loss-Of-Resistance(LOR) Syringe Market Size by Application
9.2.1 Latin America Loss-Of-Resistance(LOR) Syringe Sales by Application (2016-2027)
9.2.2 Latin America Loss-Of-Resistance(LOR) Syringe Revenue by Application (2016-2027)
9.3 Latin America Loss-Of-Resistance(LOR) Syringe Market Size by Country
9.3.1 Latin America Loss-Of-Resistance(LOR) Syringe Sales by Country (2016-2027)
9.3.2 Latin America Loss-Of-Resistance(LOR) Syringe Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia

10 Middle East and Africa
10.1 Middle East and Africa Loss-Of-Resistance(LOR) Syringe Market Size by Type
10.1.1 Middle East and Africa Loss-Of-Resistance(LOR) Syringe Sales by Type (2016-2027)
10.1.2 Middle East and Africa Loss-Of-Resistance(LOR) Syringe Revenue by Type (2016-2027)
10.2 Middle East and Africa Loss-Of-Resistance(LOR) Syringe Market Size by Application
10.2.1 Middle East and Africa Loss-Of-Resistance(LOR) Syringe Sales by Application (2016-2027)
10.2.2 Middle East and Africa Loss-Of-Resistance(LOR) Syringe Revenue by Application (2016-2027)
10.3 Middle East and Africa Loss-Of-Resistance(LOR) Syringe Market Size by Country
10.3.1 Middle East and Africa Loss-Of-Resistance(LOR) Syringe Sales by Country (2016-2027)
10.3.2 Middle East and Africa Loss-Of-Resistance(LOR) Syringe Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia

11 Company Profiles
11.1 B Braun Medical
11.1.1 B Braun Medical Corporation Information
11.1.2 B Braun Medical Overview
11.1.3 B Braun Medical Loss-Of-Resistance(LOR) Syringe Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 B Braun Medical Loss-Of-Resistance(LOR) Syringe Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 B Braun Medical Recent Developments
11.2 Smiths Medical
11.2.1 Smiths Medical Corporation Information
11.2.2 Smiths Medical Overview
11.2.3 Smiths Medical Loss-Of-Resistance(LOR) Syringe Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Smiths Medical Loss-Of-Resistance(LOR) Syringe Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Smiths Medical Recent Developments
11.3 Spectra Medical Devices
11.3.1 Spectra Medical Devices Corporation Information
11.3.2 Spectra Medical Devices Overview
11.3.3 Spectra Medical Devices Loss-Of-Resistance(LOR) Syringe Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Spectra Medical Devices Loss-Of-Resistance(LOR) Syringe Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Spectra Medical Devices Recent Developments
11.4 Busse Hospital Disposables
11.4.1 Busse Hospital Disposables Corporation Information
11.4.2 Busse Hospital Disposables Overview
11.4.3 Busse Hospital Disposables Loss-Of-Resistance(LOR) Syringe Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Busse Hospital Disposables Loss-Of-Resistance(LOR) Syringe Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Busse Hospital Disposables Recent Developments
11.5 Medline
11.5.1 Medline Corporation Information
11.5.2 Medline Overview
11.5.3 Medline Loss-Of-Resistance(LOR) Syringe Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Medline Loss-Of-Resistance(LOR) Syringe Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Medline Recent Developments
11.6 Teleflex Medical
11.6.1 Teleflex Medical Corporation Information
11.6.2 Teleflex Medical Overview
11.6.3 Teleflex Medical Loss-Of-Resistance(LOR) Syringe Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Teleflex Medical Loss-Of-Resistance(LOR) Syringe Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Teleflex Medical Recent Developments
11.7 BD
11.7.1 BD Corporation Information
11.7.2 BD Overview
11.7.3 BD Loss-Of-Resistance(LOR) Syringe Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 BD Loss-Of-Resistance(LOR) Syringe Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 BD Recent Developments
11.8 Halyard Health
11.8.1 Halyard Health Corporation Information
11.8.2 Halyard Health Overview
11.8.3 Halyard Health Loss-Of-Resistance(LOR) Syringe Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Halyard Health Loss-Of-Resistance(LOR) Syringe Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Halyard Health Recent Developments
11.9 Avanos Medical
11.9.1 Avanos Medical Corporation Information
11.9.2 Avanos Medical Overview
11.9.3 Avanos Medical Loss-Of-Resistance(LOR) Syringe Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Avanos Medical Loss-Of-Resistance(LOR) Syringe Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Avanos Medical Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Loss-Of-Resistance(LOR) Syringe Value Chain Analysis
12.2 Loss-Of-Resistance(LOR) Syringe Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Loss-Of-Resistance(LOR) Syringe Production Mode & Process
12.4 Loss-Of-Resistance(LOR) Syringe Sales and Marketing
12.4.1 Loss-Of-Resistance(LOR) Syringe Sales Channels
12.4.2 Loss-Of-Resistance(LOR) Syringe Distributors
12.5 Loss-Of-Resistance(LOR) Syringe Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Loss-Of-Resistance(LOR) Syringe Industry Trends
13.2 Loss-Of-Resistance(LOR) Syringe Market Drivers
13.3 Loss-Of-Resistance(LOR) Syringe Market Challenges
13.4 Loss-Of-Resistance(LOR) Syringe Market Restraints

14 Key Findings in The Global Loss-Of-Resistance(LOR) Syringe Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Loss-Of-Resistance(LOR) Syringe Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of 5 Milliliters
Table 3. Major Manufacturers of 10 Milliliters
Table 4. Major Manufacturers of Others
Table 5. Global Loss-Of-Resistance(LOR) Syringe Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Loss-Of-Resistance(LOR) Syringe Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 7. Global Loss-Of-Resistance(LOR) Syringe Sales by Region (2016-2021) & (K Units)
Table 8. Global Loss-Of-Resistance(LOR) Syringe Sales Market Share by Region (2016-2021)
Table 9. Global Loss-Of-Resistance(LOR) Syringe Sales by Region (2022-2027) & (K Units)
Table 10. Global Loss-Of-Resistance(LOR) Syringe Sales Market Share by Region (2022-2027)
Table 11. Global Loss-Of-Resistance(LOR) Syringe Revenue by Region (2016-2021) & (US$ Million)
Table 12. Global Loss-Of-Resistance(LOR) Syringe Revenue Market Share by Region (2016-2021)
Table 13. Global Loss-Of-Resistance(LOR) Syringe Revenue by Region (2022-2027) & (US$ Million)
Table 14. Global Loss-Of-Resistance(LOR) Syringe Revenue Market Share by Region (2022-2027)
Table 15. Global Loss-Of-Resistance(LOR) Syringe Sales by Manufacturers (2016-2021) & (K Units)
Table 16. Global Loss-Of-Resistance(LOR) Syringe Sales Share by Manufacturers (2016-2021)
Table 17. Global Loss-Of-Resistance(LOR) Syringe Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 18. Global Loss-Of-Resistance(LOR) Syringe Revenue Share by Manufacturers (2016-2021)
Table 19. Loss-Of-Resistance(LOR) Syringe Price by Manufacturers 2016-2021 (US$/Unit)
Table 20. Global Loss-Of-Resistance(LOR) Syringe Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Loss-Of-Resistance(LOR) Syringe by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Loss-Of-Resistance(LOR) Syringe as of 2020)
Table 22. Loss-Of-Resistance(LOR) Syringe Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Loss-Of-Resistance(LOR) Syringe Product Offered
Table 24. Date of Manufacturers Enter into Loss-Of-Resistance(LOR) Syringe Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Loss-Of-Resistance(LOR) Syringe Sales by Type (2016-2021) & (K Units)
Table 27. Global Loss-Of-Resistance(LOR) Syringe Sales by Type (2022-2027) & (K Units)
Table 28. Global Loss-Of-Resistance(LOR) Syringe Sales Share by Type (2016-2021)
Table 29. Global Loss-Of-Resistance(LOR) Syringe Sales Share by Type (2022-2027)
Table 30. Global Loss-Of-Resistance(LOR) Syringe Revenue by Type (2016-2021) & (US$ Million)
Table 31. Global Loss-Of-Resistance(LOR) Syringe Revenue by Type (2022-2027) & (US$ Million)
Table 32. Global Loss-Of-Resistance(LOR) Syringe Revenue Share by Type (2016-2021)
Table 33. Global Loss-Of-Resistance(LOR) Syringe Revenue Share by Type (2022-2027)
Table 34. Loss-Of-Resistance(LOR) Syringe Price by Type (2016-2021) & (US$/Unit)
Table 35. Global Loss-Of-Resistance(LOR) Syringe Price Forecast by Type (2022-2027) & (US$/Unit)
Table 36. Global Loss-Of-Resistance(LOR) Syringe Sales by Application (2016-2021) & (K Units)
Table 37. Global Loss-Of-Resistance(LOR) Syringe Sales by Application (2022-2027) & (K Units)
Table 38. Global Loss-Of-Resistance(LOR) Syringe Sales Share by Application (2016-2021)
Table 39. Global Loss-Of-Resistance(LOR) Syringe Sales Share by Application (2022-2027)
Table 40. Global Loss-Of-Resistance(LOR) Syringe Revenue by Application (2016-2021) & (US$ Million)
Table 41. Global Loss-Of-Resistance(LOR) Syringe Revenue by Application (2022-2027) & (US$ Million)
Table 42. Global Loss-Of-Resistance(LOR) Syringe Revenue Share by Application (2016-2021)
Table 43. Global Loss-Of-Resistance(LOR) Syringe Revenue Share by Application (2022-2027)
Table 44. Loss-Of-Resistance(LOR) Syringe Price by Application (2016-2021) & (US$/Unit)
Table 45. Global Loss-Of-Resistance(LOR) Syringe Price Forecast by Application (2022-2027) & (US$/Unit)
Table 46. North America Loss-Of-Resistance(LOR) Syringe Sales by Type (2016-2021) & (K Units)
Table 47. North America Loss-Of-Resistance(LOR) Syringe Sales by Type (2022-2027) & (K Units)
Table 48. North America Loss-Of-Resistance(LOR) Syringe Revenue by Type (2016-2021) & (US$ Million)
Table 49. North America Loss-Of-Resistance(LOR) Syringe Revenue by Type (2022-2027) & (US$ Million)
Table 50. North America Loss-Of-Resistance(LOR) Syringe Sales by Application (2016-2021) & (K Units)
Table 51. North America Loss-Of-Resistance(LOR) Syringe Sales by Application (2022-2027) & (K Units)
Table 52. North America Loss-Of-Resistance(LOR) Syringe Revenue by Application (2016-2021) & (US$ Million)
Table 53. North America Loss-Of-Resistance(LOR) Syringe Revenue by Application (2022-2027) & (US$ Million)
Table 54. North America Loss-Of-Resistance(LOR) Syringe Sales by Country (2016-2021) & (K Units)
Table 55. North America Loss-Of-Resistance(LOR) Syringe Sales by Country (2022-2027) & (K Units)
Table 56. North America Loss-Of-Resistance(LOR) Syringe Revenue by Country (2016-2021) & (US$ Million)
Table 57. North America Loss-Of-Resistance(LOR) Syringe Revenue by Country (2022-2027) & (US$ Million)
Table 58. Europe Loss-Of-Resistance(LOR) Syringe Sales by Type (2016-2021) & (K Units)
Table 59. Europe Loss-Of-Resistance(LOR) Syringe Sales by Type (2022-2027) & (K Units)
Table 60. Europe Loss-Of-Resistance(LOR) Syringe Revenue by Type (2016-2021) & (US$ Million)
Table 61. Europe Loss-Of-Resistance(LOR) Syringe Revenue by Type (2022-2027) & (US$ Million)
Table 62. Europe Loss-Of-Resistance(LOR) Syringe Sales by Application (2016-2021) & (K Units)
Table 63. Europe Loss-Of-Resistance(LOR) Syringe Sales by Application (2022-2027) & (K Units)
Table 64. Europe Loss-Of-Resistance(LOR) Syringe Revenue by Application (2016-2021) & (US$ Million)
Table 65. Europe Loss-Of-Resistance(LOR) Syringe Revenue by Application (2022-2027) & (US$ Million)
Table 66. Europe Loss-Of-Resistance(LOR) Syringe Sales by Country (2016-2021) & (K Units)
Table 67. Europe Loss-Of-Resistance(LOR) Syringe Sales by Country (2022-2027) & (K Units)
Table 68. Europe Loss-Of-Resistance(LOR) Syringe Revenue by Country (2016-2021) & (US$ Million)
Table 69. Europe Loss-Of-Resistance(LOR) Syringe Revenue by Country (2022-2027) & (US$ Million)
Table 70. Asia Pacific Loss-Of-Resistance(LOR) Syringe Sales by Type (2016-2021) & (K Units)
Table 71. Asia Pacific Loss-Of-Resistance(LOR) Syringe Sales by Type (2022-2027) & (K Units)
Table 72. Asia Pacific Loss-Of-Resistance(LOR) Syringe Revenue by Type (2016-2021) & (US$ Million)
Table 73. Asia Pacific Loss-Of-Resistance(LOR) Syringe Revenue by Type (2022-2027) & (US$ Million)
Table 74. Asia Pacific Loss-Of-Resistance(LOR) Syringe Sales by Application (2016-2021) & (K Units)
Table 75. Asia Pacific Loss-Of-Resistance(LOR) Syringe Sales by Application (2022-2027) & (K Units)
Table 76. Asia Pacific Loss-Of-Resistance(LOR) Syringe Revenue by Application (2016-2021) & (US$ Million)
Table 77. Asia Pacific Loss-Of-Resistance(LOR) Syringe Revenue by Application (2022-2027) & (US$ Million)
Table 78. Asia Pacific Loss-Of-Resistance(LOR) Syringe Sales by Region (2016-2021) & (K Units)
Table 79. Asia Pacific Loss-Of-Resistance(LOR) Syringe Sales by Region (2022-2027) & (K Units)
Table 80. Asia Pacific Loss-Of-Resistance(LOR) Syringe Revenue by Region (2016-2021) & (US$ Million)
Table 81. Asia Pacific Loss-Of-Resistance(LOR) Syringe Revenue by Region (2022-2027) & (US$ Million)
Table 82. Latin America Loss-Of-Resistance(LOR) Syringe Sales by Type (2016-2021) & (K Units)
Table 83. Latin America Loss-Of-Resistance(LOR) Syringe Sales by Type (2022-2027) & (K Units)
Table 84. Latin America Loss-Of-Resistance(LOR) Syringe Revenue by Type (2016-2021) & (US$ Million)
Table 85. Latin America Loss-Of-Resistance(LOR) Syringe Revenue by Type (2022-2027) & (US$ Million)
Table 86. Latin America Loss-Of-Resistance(LOR) Syringe Sales by Application (2016-2021) & (K Units)
Table 87. Latin America Loss-Of-Resistance(LOR) Syringe Sales by Application (2022-2027) & (K Units)
Table 88. Latin America Loss-Of-Resistance(LOR) Syringe Revenue by Application (2016-2021) & (US$ Million)
Table 89. Latin America Loss-Of-Resistance(LOR) Syringe Revenue by Application (2022-2027) & (US$ Million)
Table 90. Latin America Loss-Of-Resistance(LOR) Syringe Sales by Country (2016-2021) & (K Units)
Table 91. Latin America Loss-Of-Resistance(LOR) Syringe Sales by Country (2022-2027) & (K Units)
Table 92. Latin America Loss-Of-Resistance(LOR) Syringe Revenue by Country (2016-2021) & (US$ Million)
Table 93. Latin America Loss-Of-Resistance(LOR) Syringe Revenue by Country (2022-2027) & (US$ Million)
Table 94. Middle East and Africa Loss-Of-Resistance(LOR) Syringe Sales by Type (2016-2021) & (K Units)
Table 95. Middle East and Africa Loss-Of-Resistance(LOR) Syringe Sales by Type (2022-2027) & (K Units)
Table 96. Middle East and Africa Loss-Of-Resistance(LOR) Syringe Revenue by Type (2016-2021) & (US$ Million)
Table 97. Middle East and Africa Loss-Of-Resistance(LOR) Syringe Revenue by Type (2022-2027) & (US$ Million)
Table 98. Middle East and Africa Loss-Of-Resistance(LOR) Syringe Sales by Application (2016-2021) & (K Units)
Table 99. Middle East and Africa Loss-Of-Resistance(LOR) Syringe Sales by Application (2022-2027) & (K Units)
Table 100. Middle East and Africa Loss-Of-Resistance(LOR) Syringe Revenue by Application (2016-2021) & (US$ Million)
Table 101. Middle East and Africa Loss-Of-Resistance(LOR) Syringe Revenue by Application (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Loss-Of-Resistance(LOR) Syringe Sales by Country (2016-2021) & (K Units)
Table 103. Middle East and Africa Loss-Of-Resistance(LOR) Syringe Sales by Country (2022-2027) & (K Units)
Table 104. Middle East and Africa Loss-Of-Resistance(LOR) Syringe Revenue by Country (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Loss-Of-Resistance(LOR) Syringe Revenue by Country (2022-2027) & (US$ Million)
Table 106. B Braun Medical Corporation Information
Table 107. B Braun Medical Description and Major Businesses
Table 108. B Braun Medical Loss-Of-Resistance(LOR) Syringe Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 109. B Braun Medical Loss-Of-Resistance(LOR) Syringe Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. B Braun Medical Recent Developments
Table 111. Smiths Medical Corporation Information
Table 112. Smiths Medical Description and Major Businesses
Table 113. Smiths Medical Loss-Of-Resistance(LOR) Syringe Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 114. Smiths Medical Loss-Of-Resistance(LOR) Syringe Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Smiths Medical Recent Developments
Table 116. Spectra Medical Devices Corporation Information
Table 117. Spectra Medical Devices Description and Major Businesses
Table 118. Spectra Medical Devices Loss-Of-Resistance(LOR) Syringe Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 119. Spectra Medical Devices Loss-Of-Resistance(LOR) Syringe Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Spectra Medical Devices Recent Developments
Table 121. Busse Hospital Disposables Corporation Information
Table 122. Busse Hospital Disposables Description and Major Businesses
Table 123. Busse Hospital Disposables Loss-Of-Resistance(LOR) Syringe Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 124. Busse Hospital Disposables Loss-Of-Resistance(LOR) Syringe Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Busse Hospital Disposables Recent Developments
Table 126. Medline Corporation Information
Table 127. Medline Description and Major Businesses
Table 128. Medline Loss-Of-Resistance(LOR) Syringe Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 129. Medline Loss-Of-Resistance(LOR) Syringe Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Medline Recent Developments
Table 131. Teleflex Medical Corporation Information
Table 132. Teleflex Medical Description and Major Businesses
Table 133. Teleflex Medical Loss-Of-Resistance(LOR) Syringe Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 134. Teleflex Medical Loss-Of-Resistance(LOR) Syringe Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Teleflex Medical Recent Developments
Table 136. BD Corporation Information
Table 137. BD Description and Major Businesses
Table 138. BD Loss-Of-Resistance(LOR) Syringe Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 139. BD Loss-Of-Resistance(LOR) Syringe Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. BD Recent Developments
Table 141. Halyard Health Corporation Information
Table 142. Halyard Health Description and Major Businesses
Table 143. Halyard Health Loss-Of-Resistance(LOR) Syringe Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 144. Halyard Health Loss-Of-Resistance(LOR) Syringe Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Halyard Health Recent Developments
Table 146. Avanos Medical Corporation Information
Table 147. Avanos Medical Description and Major Businesses
Table 148. Avanos Medical Loss-Of-Resistance(LOR) Syringe Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 149. Avanos Medical Loss-Of-Resistance(LOR) Syringe Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Avanos Medical Recent Developments
Table 151. Key Raw Materials Lists
Table 152. Raw Materials Key Suppliers Lists
Table 153. Loss-Of-Resistance(LOR) Syringe Distributors List
Table 154. Loss-Of-Resistance(LOR) Syringe Customers List
Table 155. Loss-Of-Resistance(LOR) Syringe Market Trends
Table 156. Loss-Of-Resistance(LOR) Syringe Market Drivers
Table 157. Loss-Of-Resistance(LOR) Syringe Market Challenges
Table 158. Loss-Of-Resistance(LOR) Syringe Market Restraints
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Loss-Of-Resistance(LOR) Syringe Product Picture
Figure 2. Global Loss-Of-Resistance(LOR) Syringe Market Share by Type in 2020 & 2027
Figure 3. 5 Milliliters Product Picture
Figure 4. 10 Milliliters Product Picture
Figure 5. Others Product Picture
Figure 6. Global Loss-Of-Resistance(LOR) Syringe Market Share by Application in 2020 & 2027
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Laboratory
Figure 10. Others
Figure 11. Loss-Of-Resistance(LOR) Syringe Report Years Considered
Figure 12. Global Loss-Of-Resistance(LOR) Syringe Sales 2016-2027 (K Units)
Figure 13. Global Loss-Of-Resistance(LOR) Syringe Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Loss-Of-Resistance(LOR) Syringe Revenue 2016-2027 (US$ Million)
Figure 15. Global Loss-Of-Resistance(LOR) Syringe Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 16. Global Loss-Of-Resistance(LOR) Syringe Sales Market Share by Region (2016-2021)
Figure 17. Global Loss-Of-Resistance(LOR) Syringe Sales Market Share by Region (2022-2027)
Figure 18. North America Loss-Of-Resistance(LOR) Syringe Sales YoY (2016-2027) & (K Units)
Figure 19. North America Loss-Of-Resistance(LOR) Syringe Revenue YoY (2016-2027) & (US$ Million)
Figure 20. Europe Loss-Of-Resistance(LOR) Syringe Sales YoY (2016-2027) & (K Units)
Figure 21. Europe Loss-Of-Resistance(LOR) Syringe Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Asia-Pacific Loss-Of-Resistance(LOR) Syringe Sales YoY (2016-2027) & (K Units)
Figure 23. Asia-Pacific Loss-Of-Resistance(LOR) Syringe Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Latin America Loss-Of-Resistance(LOR) Syringe Sales YoY (2016-2027) & (K Units)
Figure 25. Latin America Loss-Of-Resistance(LOR) Syringe Revenue YoY (2016-2027) & (US$ Million)
Figure 26. Middle East & Africa Loss-Of-Resistance(LOR) Syringe Sales YoY (2016-2027) & (K Units)
Figure 27. Middle East & Africa Loss-Of-Resistance(LOR) Syringe Revenue YoY (2016-2027) & (US$ Million)
Figure 28. The Top 10 and Top 5 Players Market Share by Loss-Of-Resistance(LOR) Syringe Sales in 2020
Figure 29. The Top 10 and Top 5 Players Market Share by Loss-Of-Resistance(LOR) Syringe Revenue in 2020
Figure 30. Loss-Of-Resistance(LOR) Syringe Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 31. Global Loss-Of-Resistance(LOR) Syringe Sales Market Share by Type (2016-2027)
Figure 32. Global Loss-Of-Resistance(LOR) Syringe Revenue Market Share by Type (2016-2027)
Figure 33. Global Loss-Of-Resistance(LOR) Syringe Sales Market Share by Application (2016-2027)
Figure 34. Global Loss-Of-Resistance(LOR) Syringe Revenue Market Share by Application (2016-2027)
Figure 35. North America Loss-Of-Resistance(LOR) Syringe Sales Market Share by Type (2016-2027)
Figure 36. North America Loss-Of-Resistance(LOR) Syringe Revenue Market Share by Type (2016-2027)
Figure 37. North America Loss-Of-Resistance(LOR) Syringe Sales Market Share by Application (2016-2027)
Figure 38. North America Loss-Of-Resistance(LOR) Syringe Revenue Market Share by Application (2016-2027)
Figure 39. North America Loss-Of-Resistance(LOR) Syringe Sales Share by Country (2016-2027)
Figure 40. North America Loss-Of-Resistance(LOR) Syringe Revenue Share by Country (2016-2027)
Figure 41. United States Loss-Of-Resistance(LOR) Syringe Revenue (2016-2027) & (US$ Million)
Figure 42. Canada Loss-Of-Resistance(LOR) Syringe Revenue (2016-2027) & (US$ Million)
Figure 43. Europe Loss-Of-Resistance(LOR) Syringe Sales Market Share by Type (2016-2027)
Figure 44. Europe Loss-Of-Resistance(LOR) Syringe Revenue Market Share by Type (2016-2027)
Figure 45. Europe Loss-Of-Resistance(LOR) Syringe Sales Market Share by Application (2016-2027)
Figure 46. Europe Loss-Of-Resistance(LOR) Syringe Revenue Market Share by Application (2016-2027)
Figure 47. Europe Loss-Of-Resistance(LOR) Syringe Sales Share by Country (2016-2027)
Figure 48. Europe Loss-Of-Resistance(LOR) Syringe Revenue Share by Country (2016-2027)
Figure 49. Germany Loss-Of-Resistance(LOR) Syringe Revenue (2016-2027) & (US$ Million)
Figure 50. France Loss-Of-Resistance(LOR) Syringe Revenue (2016-2027) & (US$ Million)
Figure 51. U.K. Loss-Of-Resistance(LOR) Syringe Revenue (2016-2027) & (US$ Million)
Figure 52. Italy Loss-Of-Resistance(LOR) Syringe Revenue (2016-2027) & (US$ Million)
Figure 53. Russia Loss-Of-Resistance(LOR) Syringe Revenue (2016-2027) & (US$ Million)
Figure 54. Asia Pacific Loss-Of-Resistance(LOR) Syringe Sales Market Share by Type (2016-2027)
Figure 55. Asia Pacific Loss-Of-Resistance(LOR) Syringe Revenue Market Share by Type (2016-2027)
Figure 56. Asia Pacific Loss-Of-Resistance(LOR) Syringe Sales Market Share by Application (2016-2027)
Figure 57. Asia Pacific Loss-Of-Resistance(LOR) Syringe Revenue Market Share by Application (2016-2027)
Figure 58. Asia Pacific Loss-Of-Resistance(LOR) Syringe Sales Share by Region (2016-2027)
Figure 59. Asia Pacific Loss-Of-Resistance(LOR) Syringe Revenue Share by Region (2016-2027)
Figure 60. China Loss-Of-Resistance(LOR) Syringe Revenue (2016-2027) & (US$ Million)
Figure 61. Japan Loss-Of-Resistance(LOR) Syringe Revenue (2016-2027) & (US$ Million)
Figure 62. South Korea Loss-Of-Resistance(LOR) Syringe Revenue (2016-2027) & (US$ Million)
Figure 63. India Loss-Of-Resistance(LOR) Syringe Revenue (2016-2027) & (US$ Million)
Figure 64. Australia Loss-Of-Resistance(LOR) Syringe Revenue (2016-2027) & (US$ Million)
Figure 65. China Taiwan Loss-Of-Resistance(LOR) Syringe Revenue (2016-2027) & (US$ Million)
Figure 66. Indonesia Loss-Of-Resistance(LOR) Syringe Revenue (2016-2027) & (US$ Million)
Figure 67. Thailand Loss-Of-Resistance(LOR) Syringe Revenue (2016-2027) & (US$ Million)
Figure 68. Malaysia Loss-Of-Resistance(LOR) Syringe Revenue (2016-2027) & (US$ Million)
Figure 69. Latin America Loss-Of-Resistance(LOR) Syringe Sales Market Share by Type (2016-2027)
Figure 70. Latin America Loss-Of-Resistance(LOR) Syringe Revenue Market Share by Type (2016-2027)
Figure 71. Latin America Loss-Of-Resistance(LOR) Syringe Sales Market Share by Application (2016-2027)
Figure 72. Latin America Loss-Of-Resistance(LOR) Syringe Revenue Market Share by Application (2016-2027)
Figure 73. Latin America Loss-Of-Resistance(LOR) Syringe Sales Share by Country (2016-2027)
Figure 74. Latin America Loss-Of-Resistance(LOR) Syringe Revenue Share by Country (2016-2027)
Figure 75. Mexico Loss-Of-Resistance(LOR) Syringe Revenue (2016-2027) & (US$ Million)
Figure 76. Brazil Loss-Of-Resistance(LOR) Syringe Revenue (2016-2027) & (US$ Million)
Figure 77. Argentina Loss-Of-Resistance(LOR) Syringe Revenue (2016-2027) & (US$ Million)
Figure 78. Colombia Loss-Of-Resistance(LOR) Syringe Revenue (2016-2027) & (US$ Million)
Figure 79. Middle East and Africa Loss-Of-Resistance(LOR) Syringe Sales Market Share by Type (2016-2027)
Figure 80. Middle East and Africa Loss-Of-Resistance(LOR) Syringe Revenue Market Share by Type (2016-2027)
Figure 81. Middle East and Africa Loss-Of-Resistance(LOR) Syringe Sales Market Share by Application (2016-2027)
Figure 82. Middle East and Africa Loss-Of-Resistance(LOR) Syringe Revenue Market Share by Application (2016-2027)
Figure 83. Middle East and Africa Loss-Of-Resistance(LOR) Syringe Sales Share by Country (2016-2027)
Figure 84. Middle East and Africa Loss-Of-Resistance(LOR) Syringe Revenue Share by Country (2016-2027)
Figure 85. Turkey Loss-Of-Resistance(LOR) Syringe Revenue (2016-2027) & (US$ Million)
Figure 86. Saudi Arabia Loss-Of-Resistance(LOR) Syringe Revenue (2016-2027) & (US$ Million)
Figure 87. UAE Loss-Of-Resistance(LOR) Syringe Revenue (2016-2027) & (US$ Million)
Figure 88. Loss-Of-Resistance(LOR) Syringe Value Chain
Figure 89. Loss-Of-Resistance(LOR) Syringe Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed

---